Adrian L. Oblak

The paper characterizes the AppSAA knock-in mouse model, showing it recapitulates age-dependent Alzheimer's disease phenotypes and provides a tool for preclinical research.

This study examines the molecular effects of aducanumab treatment in 5XFAD mice, revealing sex-dependent and IgG-mediated changes in amyloid and associated pathways.

This study identifies SHIP1 ligands with brain exposure and in vivo activity in Alzheimer's models, showing target engagement and reduced neuroinflammation.

This study shows APOE4 reduces Kir4.1 expression and mitochondrial health in Müller cells, leading to retinal impairments, and MitoQ treatment restores these functions.

This study compares two mouse models of TREM2 variants, showing both mimic Alzheimer's disease signatures in similar biological domains.

This study uses microfluidic platforms to model human retinal ganglion cell compartmentalization, showing axonal deficits in disease and astrocyte reactivity-induced neurodegeneration.

This study shows that pulmonary hypertension increases microglia and astrocyte density, reduces neuronal density, and causes TDP-43 mislocalization in both rat and human brain tissue.

This study shows that long-term dietary fat intake affects retinal health differently in APOE3 and APOE4 mice, with APOE4 mice showing greater vulnerability to Western diet-induced metabolic and retinal impairments.

The paper shows partial Wwox loss of function in mice worsens sepsis severity and neuroinflammation.

This study examines the proteomic and transcriptomic effects of SHIP1 modulation in microglia, revealing significant proteomic changes in SHIP1 homozygous knockout and differences between BV2 and HMC3 cell lines.

This study characterizes molecular and synaptic changes in a mouse model of late-onset Alzheimer's disease under different dietary conditions, showing age-related brain volume loss and cognitive deficits.

The paper functionally validates 11 genetic risk variants for late-onset Alzheimer's disease using a mouse model and compares transcriptomic effects to human cohorts.

The paper identifies a PLCG2 variant, PLCG2M28L, associated with increased Alzheimer's disease risk and altered microglial phenotypes, while another variant, PLCG2P522R, reduces disease risk in a mouse model.

This study shows that a high fat-high sugar diet interacts with the Plcg2M28L genetic variant to accelerate Alzheimer's disease-like phenotypes in mice.

This study shows INPP5D expression increases in Alzheimer's disease, particularly in plaque-associated microglia, and suggests it may be a risk factor and therapeutic target.

The paper introduces a NanoString nCounter Mouse AD panel to assess LOAD mouse models by correlating gene expression with human AD modules, showing strong correlation with RNA-Seq data.

The paper identifies a rare PLCG2 variant that increases Alzheimer's disease risk and shows increased PLCG2 expression correlates with amyloid deposition in AD patients.